Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-03T08:48:02.275Z Has data issue: false hasContentIssue false
  • English
  • Français

Correspondence on ‘Vocal fold paralysis following first dose of Oxford-AstraZeneca coronavirus disease 2019 vaccine’

Published online by Cambridge University Press:  03 August 2023

R Mungmunpuntipantip Open the ORCID record for R Mungmunpuntipantip [Opens in a new window]  and
V Wiwanitkit
R Mungmunpuntipantip*
Affiliation:
Private Academic Consultant, Bangkok, Thailand
V Wiwanitkit
Affiliation:
Honorary Professor, Dr DY Patil University, Pune, India
*
Corresponding author: Rujittika Mungmunpuntipantip Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Letters to the Editor
Information
The Journal of Laryngology & Otology , Volume 137 , Issue 10 , October 2023 , pp. 1178
Copyright
Copyright © The Author(s), 2023. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Dear Editors,

We would like to share ideas on the publication ‘Vocal fold paralysis following first dose of Oxford-AstraZeneca coronavirus disease 2019 vaccine’.Reference Jama, Amin, Hassaan and Kaddour1 We agree that the adverse effect of coronavirus disease 2019 (Covid-19) vaccination exists and the effect on the vocal fold might be possible. This clinical entity is rare and acute voice change is the common clinical presentation.Reference Perez, Sims and Mularczyk2 Inflammation of the vocal fold is a basic finding from examination.Reference Perez, Sims and Mularczyk2

In the present case, the vaccine recipient had vocal fold paralysis; however, it is still difficult to conclude as to the clinical association. There are no data on pre-vaccination immune status or laryngological status in the present case. The vocal fold problem might be due to a background personal illness or concurrent medical problem. For example, a Covid-19 vaccine recipient might have concurrent dengueReference Kebayoon and Wiwanitkit3 and dengue is a possible rare cause of vocal fold paralysis.Reference Tamilarasan, Chandra, Mohan and Kadambi4

Footnotes

*

Joint first authors

References

Jama, GM, Amin, M, Hassaan, A, Kaddour, H. Vocal fold paralysis following first dose of Oxford-AstraZeneca coronavirus disease 2019 vaccine. J Laryngol Otol 2022;136:466–8CrossRefGoogle ScholarPubMed
Perez, B, Sims, HS, Mularczyk, C. Vocal cord paresis: a case report on a novel complication of the mode RNA COVID-19 vaccine. Otolaryngology 2021;165(1 Suppl):242Google Scholar
Kebayoon, A, Wiwanitkit, V. Dengue after COVID-19 vaccination: possible and might be missed. Clin Appl Thromb Hemost 2021 Jan-Dec;27:10760296211047229CrossRefGoogle ScholarPubMed
Tamilarasan, V, Chandra, MRKR, Mohan, BVM, Kadambi, M. Vocal cord hematoma: an unusual complication of dengue fever. Egypt J Intern Med 2018;30:168–9CrossRefGoogle Scholar